SCHEMBL4757341

SCHEMBL4757341

Cc1cc(Cl)c(C(=O)Nc2nc(S(C)(=O)=O)cs2)cc1Cl

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR27 Q9NS67 2/20 0.43
GCK P35557 3/20 0.43
NPC1 O15118 7/20 0.43
RAB9A P51151 7/20 0.43
ALDH1A1 P00352 3/20 0.43
GAA P10253 3/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
KDM4E B2RXH2 2/20 0.41
RXFP1 Q9HBX9 1/20 0.41
ABL1 P00519 1/20 0.41
SMN1; SMN2 Q16637 4/20 0.41
HPGD P15428 3/20 0.41
PKM P14618 1/20 0.41
RECQL P46063 1/20 0.41
PYGL P06737 1/20 0.40
PDE5A O76074 1/20 0.40
GRM5 P41594 1/20 0.39
HTT P42858 2/20 0.39
TP53 P04637 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4757332 0.94 GCK (0.44) GCKNPC1RAB9AALDH1A1GAA
SCHEMBL4757308 0.90 KDM4E (0.41) GCKNPC1RAB9AALDH1A1GAA
SCHEMBL10114719 0.83 KDM4E (0.39) GCKNPC1RAB9AALDH1A1GAA
SCHEMBL10114672 0.83 MAPK1 (0.39) GCKNPC1RAB9AALDH1A1GAA
SCHEMBL4757068 0.81 GCK (0.46) GCKNPC1RAB9AALDH1A1GAA
SCHEMBL4757274 0.80 NPC1 (0.39) GCKNPC1RAB9AALDH1A1GAA
SCHEMBL4757088 0.80 NPC1 (0.44) GCKNPC1RAB9AALDH1A1GAA
SCHEMBL4757082 0.80 NPC1 (0.54) GCKNPC1RAB9AALDH1A1GAA
SCHEMBL4757291 0.79 NPC1 (0.49) GPR27GCKNPC1RAB9AALDH1A1
SCHEMBL4757325 0.78 SORT1 (0.43) GCKNPC1RAB9AALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8895752-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES L.C. (US) 2014-11-25 US disclosed
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES, L.C. 2012-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS HAVCR2, EIF2AK2, AADAC GPR27 3162/4885GCK 1360/4885NPC1 585/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.